Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
LINCOLNSHIRE, Ill., Aug. 03, 2017 (GLOBE NEWSWIRE) -- CDW Corporation (NASDAQ:CDW) today announced that its Board of Directors has authorized a $750 million increase to the company’s common stock...
-
Eliminates quarterly dividendAuthorizes share repurchase program LITTLE ROCK, Ark., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Windstream Holdings, Inc. (NASDAQ:WIN), a leading provider of advanced network...
-
MADISON, Wis., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Sonic Foundry, Inc. (NASDAQ: SOFO), the trusted leader for video creation and management solutions, today announced it will release its fiscal third...
-
Achieved sequential growth in Adjusted OIBDARGrew ILEC Consumer ARPU for 10th consecutive quarterExpanded enterprise contribution marginUpdated financial guidance for acquisition of Broadview Networks...
-
HOUSTON, Aug. 03, 2017 (GLOBE NEWSWIRE) -- American Electric Technologies, Inc. (NASDAQ:AETI) (the “Company”), a leading supplier of power delivery solutions for the global energy industry, today...
-
HOUSTON, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Allegiance Bancshares, Inc. ("Allegiance") (NASDAQ:ABTX), the holding company of Allegiance Bank, today announced the addition of Dr. Robert Ivany to...
-
NEWARK, N.Y., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating income of $1.3 million on revenue of $19.9 million for the second quarter ended July 2, 2017. ...
-
– OLINVO program on track for NDA submission in September/October 2017 – – First-time-in-human study of TRV250 for acute treatment of migraine remains on track; results expected in 2H 2017 – ...
-
TULSA, Okla., Aug. 03, 2017 (GLOBE NEWSWIRE) -- AAON, Inc. (NASDAQ:AAON) today announced its operating results for the second quarter and six months ended June 30, 2017. In the quarter ended...
-
HOUSTON, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood...